Team:TU Delft/29 July 2010 content
From 2010.igem.org
(Difference between revisions)
Line 154: | Line 154: | ||
|✓ | |✓ | ||
|‘X–B0015-P’ | |‘X–B0015-P’ | ||
+ | |} | ||
+ | |||
+ | The digestion products were [[Team:TU_Delft/protocols/ligation|ligated]] overnight: | ||
+ | |||
+ | {| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | ||
+ | |'''#''' | ||
+ | |'''BioBrick''' | ||
+ | |'''Fragment 1''' | ||
+ | |'''Fragment 2''' | ||
+ | |'''Final volume''' | ||
+ | |- | ||
+ | |1 | ||
+ | | | ||
+ | |4 μL ‘E–007–S’ | ||
+ | |4 μL ‘X–00–P’ | ||
+ | | | ||
+ | |- | ||
+ | |2 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
+ | |- | ||
+ | |3 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
+ | |- | ||
+ | |4 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
+ | |- | ||
+ | |5 | ||
+ | | | ||
+ | |? μL ‘E-Part1-S’ | ||
+ | |? μL ‘X-Part2-P' | ||
+ | | | ||
+ | |- | ||
+ | |6 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
+ | |- | ||
+ | |7 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
+ | |- | ||
+ | |8 | ||
+ | | | ||
+ | |? μL ‘E – Part – S’ | ||
+ | |? μL ‘X – Part – P’ | ||
+ | | | ||
|} | |} |
Revision as of 07:11, 2 August 2010
Lab work
Alkane Degradation
PCR Amplification
K398007A, K398008A, K398009A, K398010A, K398017A, K398018A, K398019A, B0015 were amplified with the universal primers G00100 and G00101. The product was put on 1% agarose gel:
Lane Description:
# | Description | Expected Length (bp) | Primers | Status | Remarks |
M1 | SmartLadder | n/a | n/a | n/a | |
1 | PCR product of 007 | 1616 | G00101 + G00101 | ✔ | |
2 | PCR product of 008 | 473 | G00101 + G00101 | ✔ | |
3 | PCR product of 009 | 482 | G00101 + G00101 | ✔ | |
4 | PCR product of 010 | 1505 | G00101 + G00101 | ✔ | |
5 | PCR product of 017 | 1625 | G00101 + G00101 | ✔ | |
6 | PCR product of 018 | 1052 | G00101 + G00101 | ✔ | |
7 | PCR product of 019 | 1796 | G00101 + G00101 | ✔ | |
8 | PCR product of B0015 | 445 | G00101 + G00101 | ✔ |
The PCR products were subsequently digested:
# | Sample | Enzyme 1 | Enzyme 2 | Buffer | BSA | Needed fragment |
1 | 40 μL PCR product 007 | EcoRI | SpeI | 2 (BioLabs) | ✓ | ‘E–007–S’ |
2 | 40 μL PCR product 008 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–008-P’ |
3 | 40 μL PCR product 009 | EcoRI | SpeI | 2 (BioLabs) | ✓ | ‘E–009–S’ |
4 | 40 μL PCR product 010 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–010-P’ |
5 | 40 μL PCR product 017 | EcoRI | SpeI | 2 (BioLabs) | ✓ | ‘E–009–S’ |
6 | 40 μL PCR product 018 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–018-P’ |
7 | 40 μL PCR product 019 | EcoRI | SpeI | 2 (BioLabs) | ✓ | ‘E–019-S’ |
8 | 40 μL PCR product B0015 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–B0015-P’ |
The digestion products were ligated overnight:
# | BioBrick | Fragment 1 | Fragment 2 | Final volume |
1 | 4 μL ‘E–007–S’ | 4 μL ‘X–00–P’ | ||
2 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ | ||
3 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ | ||
4 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ | ||
5 | ? μL ‘E-Part1-S’ | ? μL ‘X-Part2-P' | ||
6 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ | ||
7 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ | ||
8 | ? μL ‘E – Part – S’ | ? μL ‘X – Part – P’ |